News

Corporate News

11:08 | 19/03/2021

IMP: FINANCIAL STATEMENTS FOT THE YEAR ENDED 31 DECEMBER 2020

IMP: Information on the Annual Report 2019 via the website

11:08 | 19/03/2021

IMP: Information on the Annual Report 2019 via the website
IMP: Resolution of Annual General Meeting 2018

11:08 | 19/03/2021

Imexpharm Corporation announces Resolution of 2018 AGM as follows:
IMP: Posts VND162.6 Bln Pre-tax Profit in 2017, Targets VND190 Bln Pre-tax Profit in 2018

11:08 | 19/03/2021
IMP: Makes VND111 Bln Pre-tax Profit in 9M/2017, up 40% YoY

11:08 | 19/03/2021
IMP: Posts VND23.1 Bln Net Profit in Q3/2016, up 31% YoY, Sales up

11:08 | 19/03/2021
IMP: Posts VND21.7 Bln Net Profit in Q4/2015, Down 1% YoY

11:08 | 19/03/2021
IMP: Targets VND140 Bln Pre-tax Profit in 2016

11:08 | 19/03/2021
IMP: Posts VND27.2Bln Net Profit in Q2/2015, up 27% YoY

11:08 | 19/03/2021

Imexpharm Corporation (IMP) posted its Q2/2015 financial statements.
IMP: Earns VND22Bln Net Profit in Q3/2012

11:08 | 19/03/2021

Imexpharm Pharmaceutical JSC. (IMP) made a net profit of VND22.2 billion in Q3/2012, slightly down from VND22.9 billion a year ago, the firm said in its quarterly financial statements.